Join
Live feed
·
INSIDERFilingvia Quantisnow
Obalon Therapeutics, Inc. logo

SEC Form 4: ARMISTICE CAPITAL, LLC sold $14,230,402 worth of Common Stock (2,303,469 units at $6.18)

ByQuantisnow·Wall Street's wire, on your screen.
OBLN· Obalon Therapeutics, Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track OBLN (Obalon Therapeutics, Inc.) and more on Quantisnow.